1. Home
  2. LMB vs ALVO Comparison

LMB vs ALVO Comparison

Compare LMB & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$72.72

Market Cap

1.2B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.38

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
ALVO
Founded
1901
2013
Country
United States
Luxembourg
Employees
1400
1460
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
LMB
ALVO
Price
$72.72
$3.38
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$116.67
$8.00
AVG Volume (30 Days)
310.6K
357.3K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
N/A
EPS
0.36
N/A
Revenue
$646,804,000.00
N/A
Revenue This Year
$15.96
$13.28
Revenue Next Year
$5.90
$18.63
P/E Ratio
$207.75
$18.20
Revenue Growth
24.68
N/A
52 Week Low
$65.08
$3.03
52 Week High
$154.04
$11.85

Technical Indicators

Market Signals
Indicator
LMB
ALVO
Relative Strength Index (RSI) 40.25 45.45
Support Level $71.40 $3.10
Resistance Level $85.38 $3.93
Average True Range (ATR) 6.95 0.20
MACD -2.73 0.01
Stochastic Oscillator 3.91 30.97

Price Performance

Historical Comparison
LMB
ALVO

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: